Filing
Spy
Filing
Spy
Home
About
RYZB
Rayzebio Inc
Radiopharmaceutical therapeutics company focused on cancer treatment
CUSIP: 75525N107
Healthcare
US
1 holder
Ownership
Activity
2023 Q4
1 of 2 quarters
Total Value
$412.98M
Total Shares
6.64M
Net Share Change
0
Activity
No changes
Investor
Value
Shares
Weight
Change
Viking Global Investors
$412.98M
6.64M
1.5%
Unchanged
Viking Global Investors
$412.98M
6.64M shares
Unchanged
RYZB — Rayzebio Inc - FilingSpy